We are live on ! Find out more
AF

Avanza Fonder Portfolio holdings

AUM $4.59B
1-Year Est. Return 41.03%
This Fund
S&P 500
This Quarter Est. Return
-3.95%
1 Year Est. Return
+41.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.61B
AUM Growth
-$328M
Cap. Flow
-$92.4M
Cap. Flow %
-2.56%
Top 10 Hldgs %
37.37%
Holding
513
New
16
Increased
123
Reduced
150
Closed
29

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$35.4M
2
MSFT icon
Microsoft
MSFT
+$13.5M
3
NVDA icon
NVIDIA
NVDA
+$13.3M
4
AVGO icon
Broadcom
AVGO
+$7.09M
5
AMZN icon
Amazon
AMZN
+$5.26M

Sector Composition

Rank Sector Weight
1 Technology 32.67%
2 Financials 13.22%
3 Consumer Discretionary 11.84%
4 Communication Services 11.62%
5 Healthcare 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIRM icon
501
Mirum Pharmaceuticals
MIRM
$6.37B
-2,677
Closed -$211K
NAMS icon
502
NewAmsterdam Pharma
NAMS
$3.21B
-6,566
Closed -$230K
NBIX icon
503
Neurocrine Biosciences
NBIX
$16.9B
-3,890
Closed -$552K
NSC icon
504
Norfolk Southern
NSC
$75.2B
-5,378
Closed -$1.55M
PYXS icon
505
Pyxis Oncology
PYXS
$186M
-27,345
Closed -$31.4K
RVMD icon
506
Revolution Medicines
RVMD
$38.9B
-3,036
Closed -$242K
SLNO
507
DELISTED
Soleno Therapeutics
SLNO
-3,195
Closed -$148K
TD icon
508
Toronto Dominion Bank
TD
$199B
-5,495
Closed -$711K
UFPT icon
509
UFP Technologies
UFPT
$2.04B
-907
Closed -$201K
UHS icon
510
Universal Health Services
UHS
$10.3B
-1,027
Closed -$224K
UNP icon
511
Union Pacific
UNP
$172B
-6,266
Closed -$1.45M
BCAX
512
Bicara Therapeutics
BCAX
$1.71B
-5,039
Closed -$84.8K
ONC
513
BeOne Medicines Ltd
ONC
$32.4B
-1,408
Closed -$428K

Similar funds

Avanza Fonder's Q1 2026 Portfolio in Review

As of Q1 2026, Avanza Fonder held 513 positions worth $3.61B, down 8.3% from $3.94B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Avanza Fonder's Q1 2026 filing shows 16 new, 123 increased, 150 reduced and 29 closed positions. Its largest new stake was Nutrien: 7,208 shares worth $757K. The largest sale was Berkshire Hathaway Class B, an estimated $35.4M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Avanza Fonder's largest Q1 2026 buy was Nutrien: 7,208 shares worth $757K.
  • Avanza Fonder added most to Procter & Gamble in Q1 2026, an estimated $2.09M increase.
  • Avanza Fonder's biggest Q1 2026 reduction was Microsoft, cutting an estimated $13.5M.
  • Avanza Fonder fully exited Berkshire Hathaway Class B in Q1 2026, selling an estimated $35.4M.
  • Avanza Fonder's ten largest holdings make up 37% of its $3.61B portfolio in Q1 2026.
  • Avanza Fonder opened 16 new positions and closed 29 in Q1 2026.
  • Avanza Fonder's portfolio value fell 8.3% quarter-over-quarter to $3.61B.

Based on Avanza Fonder's 13F filing for Q1 2026, filed 15 Apr 2026.